Literature DB >> 20401715

Coronary artery bypass grafting in patients with pulmonary aspergillosis.

Hideki Teshima1, Hiroshi Kawano, Hideyuki Kashikie, Katsuhiko Nakamura, Shigeaki Aoyagi.   

Abstract

Cardiovascular surgery in patients with pulmonary aspergillosis has been rarely reported. Coronary artery bypass grafting (CABG) for three cases of angina pectoris with pulmonary aspergillosis was successfully performed. Patients were discharged from our hospital without any complications of invasive Aspergillus cardiovascular infection. Careful perioperative management for preventing pulmonary complications is important.

Entities:  

Mesh：

Year:  2010        PMID： 20401715     DOI： 10.1007/s11748-009-0509-y

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  10 in total

Review 1.  Preoperative pulmonary evaluation.

Authors:  G W Smetana
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

2.  Changes in lymphocyte subsets and mitogen responsiveness following open-heart surgery and possible therapeutic approaches.

Authors:  A Markewitz; E Faist; T Niesel; S Lang; C Weinhold; B Reichart
Journal:  Thorac Cardiovasc Surg       Date:  1992-02       Impact factor: 1.827

3.  Effect of cardiopulmonary bypass on circulating lymphocyte function.

Authors:  D M Nguyen; D S Mulder; H Shennib
Journal:  Ann Thorac Surg       Date:  1992-04       Impact factor: 4.330

4.  Prognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting.

Authors:  Rafael García Fuster; José A Montero Argudo; Oscar Gil Albarova; Fernando Hornero Sos; Sergio Cánovas López; María Bueno Codoñer; José A Buendía Miñano; Ignacio Rodríguez Albarran
Journal:  Eur J Cardiothorac Surg       Date:  2005-12-20       Impact factor: 4.191

5.  Off-Pump Coronary Artery Bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: a United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome.

Authors:  Sharif Al-Ruzzeh; Gareth Ambler; George Asimakopoulos; Rumana Z Omar; Ragheb Hasan; Brian Fabri; Ahmed El-Gamel; Anthony DeSouza; Vipin Zamvar; Steven Griffin; Daniel Keenan; Uday Trivedi; Mark Pullan; Alex Cale; Michael Cowen; Kenneth Taylor; Mohamed Amrani
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

6.  Invasive pulmonary aspergillosis with thrombosis in the left atrium.

Authors:  K Kobayashi; S Yano; S Shishido; T Tokushima
Journal:  Intern Med       Date:  2001-03       Impact factor: 1.271

7.  Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.

Authors:  J Navarro; M Rainisio; H K Harms; M E Hodson; C Koch; G Mastella; B Strandvik; S G McKenzie
Journal:  Eur Respir J       Date:  2001-08       Impact factor: 16.671

8.  Aspergillus aortitis after cardiac surgery.

Authors:  Angel Sanchez-Recalde; Isabel Maté; José L Merino; Raquel S Simon; José A Sobrino
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

9.  A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan.

Authors:  Shigeru Kohno; Toru Masaoka; Hideyo Yamaguchi; Takeshi Mori; Akio Urabe; Akira Ito; Yoshihito Niki; Hideo Ikemoto
Journal:  Scand J Infect Dis       Date:  2004

Review 10.  The epidemiology and prevention of invasive aspergillosis.

Authors:  R J Manuel; C C Kibbler
Journal:  J Hosp Infect       Date:  1998-06       Impact factor: 3.926
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.